Neurobiology of Aging
Volume 30, Issue 7 , Pages 1061-1068 , July 2009

Presenilin-1 mutation impairs cholinergic modulation of synaptic plasticity and suppresses NMDA currents in hippocampus slices

Received 6 July 2007 ,Revised 10 October 2007 ,Accepted 18 October 2007.

References 

  1. Barrow PA, Empson RM, Gladwell SJ, Anderson CM, Killick R, Yu X, et al. Functional phenotype in transgenic mice expressing mutant human presenilin-1. Neurobiol. Dis. 2000;7:119–126
  2. Begley JG, Duan S, Chan W, Duff K, Mattson MP. Altered calcium homeostasis and mitochondrial dysfunction in cortical synaptic compartments of presenilin-1 mutant mice. J. Neurochem. 1999;72:1030–1039
  3. Billings LM, Oddo S, Green KN, McGaugh JL, LaFerla FM. Intraneuronal Abeta causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice. Neuron. 2005;45:675–688
  4. Blitzer RD, Gil O, Landau EM. Cholinergic stimulation enhances long-term potentiation in the CA1 region of rat hippocampus. Neurosci. Lett. 1990;119:207–210
  5. Chan SL, Mayne M, Holden CP, Geiger JD, Mattson MP. Presenilin-1 mutations increase levels of ryanodine receptors and calcium release in PC12 cells and cortical neurons. J. Biol. Chem. 2000;275:18195–18200
  6. Chapman PF, White GL, Jones MW, Cooper-Blacketer D, Marshall VJ, Irizarry M, et al. Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice. Nat. Neurosci. 1999;2:271–276
  7. Coleman P, Federoff H, Kurlan R. A focus on the synapse for neuroprotection in Alzheimer disease and other dementias. Neurology. 2004;63:1155–1162
  8. Collingridge GL. The induction of N-methyl-d-aspartate receptor-dependent long-term potentiation. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2003;358:635–641
  9. Dineley KT, Weeber EJ, Atkins C, Adams JP, Anderson AE, Sweatt JD. Leitmotifs in the biochemistry of LTP induction: amplification, integration and coordination. J. Neurochem. 2001;77:961–971
  10. Furukawa K, Fu W, Li Y, Witke W, Kwiatkowski DJ, Mattson MP. The actin-severing protein gelsolin modulates calcium channel and NMDA receptor activities and vulnerability to excitotoxicity in hippocampal neurons. J. Neurosci. 1997;17:8178–8186
  11. Futatsugi A, Kato K, Ogura H, Li ST, Nagata E, Kuwajima G, et al. Facilitation of NMDAR-independent LTP and spatial learning in mutant mice lacking ryanodine receptor type 3. Neuron. 1999;24:701–713
  12. Guo Q, Fu W, Sopher BL, Miller MW, Ware CB, Martin GM, et al. Increased vulnerability of hippocampal neurons to excitotoxic necrosis in presenilin-1 mutant knock-in mice. Nat. Med. 1999;5:101–106
  13. Guo Q, Sopher BL, Furukawa K, Pham DG, Robinson N, Martin GM, et al. Alzheimer's presenilin mutation sensitizes neural cells to apoptosis induced by trophic factor withdrawal and amyloid beta-peptide: involvement of calcium and oxyradicals. J. Neurosci. 1997;17:4212–4222
  14. Halagappa VK, Guo Z, Pearson M, Matsuoka Y, Cutler RG, LaFerla FM, et al. Intermittent fasting and caloric restriction ameliorate age-related behavioral deficits in the triple-transgenic mouse model of Alzheimer's disease. Neurobiol. Dis. 2007;26:212–220
  15. Hardy J. Amyloid, the presenilins and Alzheimer's disease. Trends Neurosci. 1997;20:154–159
  16. Herms J, Schneider I, Dewachter I, Caluwaerts N, Kretzschmar H, Van Leuven F. Capacitive calcium entry is directly attenuated by mutant presenilin-1, independent of the expression of the amyloid precursor protein. J. Biol. Chem. 2003;278:2484–2489
  17. Jouvenceau A, Potier B, Battini R, Ferrari S, Dutar P, Billard JM. Glutamatergic synaptic responses and long-term potentiation are impaired in the CA1 hippocampal area of calbindin D(28k)-deficient mice. Synapse. 1999;33:172–180
  18. Klyubin I, Walsh DM, Lemere CA, Cullen WK, Shankar GM, Betts V, et al. Amyloid beta protein immunotherapy neutralizes Abeta oligomers that disrupt synaptic plasticity in vivo. Nat. Med. 2005;11:556–561
  19. Legendre P, Rosenmund C, Westbrook GL. Inactivation of NMDA channels in cultured hippocampal neurons by intracellular calcium. J. Neurosci. 1993;13:674–684
  20. Leissring MA, Akbari Y, Fanger CM, Cahalan MD, Mattson MP, LaFerla FM. Capacitative calcium entry deficits and elevated luminal calcium content in mutant presenilin-1 knockin mice. J. Cell Biol. 2000;149:793–798
  21. Li S, Cullen WK, Anwy R, Rowan MJ. Muscarinic acetylcholine receptor-dependent induction of persistent synaptic enhancement in rat hippocampus in vivo. Neuroscience. 2007;144:754–761
  22. Li D, Parks SB, Kushner JD, Nauman D, Burgess D, Ludwigsen S. Mutations of presenilin genes in dilated cardiomyopathy and heart failure. Am. J. Hum. Genet. 2006;79:1030–1039
  23. Lleo A, Greenberg SM, Growdon JH. Current pharmacotherapy for Alzheimer's disease. Annu. Rev. Med. 2006;57:513–533
  24. Malenka RC, Bear MF. LTP and LTD: an embarrassment of riches. Neuron. 2004;44:5–21
  25. Mattson MP. Pathways towards and away from Alzheimer's disease. Nature. 2004;430:631–639
  26. Mattson MP, Zhu H, Yu J, Kindy MS. Presenilin-1 mutation increases neuronal vulnerability to focal ischemia in vivo and to hypoxia and glucose deprivation in cell culture: involvement of perturbed calcium homeostasis. J. Neurosci. 2000;20:1358–1364
  27. McCutchen E, Scheiderer CL, Dobrunz LE, McMahon LL. Coexistence of muscarinic long-term depression with electrically induced long-term potentiation and depression at CA3-CA1 synapses. J. Neurophysiol. 2006;96:3114–3121
  28. Muller D, Joly M, Lynch G. Contributions of quisqualate and NMDA receptors to the induction and expression of LTP. Science. 1988;242:1694–1697
  29. Nagase T, Ito KI, Kato K, Kaneko K, Kohda K, Matsumoto M. Long-term potentiation and long-term depression in hippocam pal CA1 neurons of mice lacking the IP(3) type 1 receptor. Neuroscience. 2003;117:821–830
  30. Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, Kayed R. Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron. 2003;39:409–421
  31. Oddo S, LaFerla FM. The role of nicotinic acetylcholine receptors in Alzheimer's disease. J. Physiol. (Paris). 2006;9:172–179
  32. Pack-Chung E, Meyers MB, Pettingell WP, Moir RD, Brownawelln AM, Cheng I. Presenilin 2 interacts with sorcin, a modulator of the ryanodine receptor. J. Biol. Chem. 2000;275:14440–14445
  33. Parent A, Linden DJ, Sisodia SS, Borchelt DR. Synaptic transmission and hippocampal long-term potentiation in transgenic mice expressing FAD-linked presenilin 1. Neurobiol. Dis. 1999;1:56–62
  34. Price CJ, Rintoul GL, Baimbridge KG, Raymond LA. Inhibition of calcium-dependent NMDA receptor current rundown by calbindin-D28k. J. Neurochem. 1999;72:634–642
  35. Rademakers R, Cruts M, Van Broeckhoven C. Genetics of early-onset Alzheimer dementia. Sci. World J. 2003;3:497–519
  36. Raymond CR, Redman SJ. Different calcium sources are narrowly tuned to the induction of different forms of LTP. J. Neurophysiol. 2002;88:249–255
  37. Selkoe DJ. Alzheimer's disease is a synaptic failure. Science. 2002;298:789–791
  38. Shen J, Kelleher RJ. The presenilin hypothesis of Alzheimer's disease: evidence for a loss-of-function pathogenic mechanism. Proc. Natl. Acad. Sci. U.S.A. 2007;104:403–409
  39. Shinoe T, Matsui M, Taketo MM, Manabe T. Modulation of synaptic plasticity by physiological activation of M1 muscarinic a cetylcholine receptors in the mouse hippocampus. J. Neurosci. 2005;25:11194–11200
  40. Smith IF, Hitt B, Green KN, Oddo S, LaFerla FM. Enhanced caffeine-induced Ca2+ release in the 3xTg-AD mouse model of Alzheimer's disease. J. Neurochem. 2005;9:1711–1718
  41. Stutzmann GE, Smith I, Caccamo A, Oddo S, Laferla FM, Parker I. Enhanced ryanodine receptor recruitment contributes to Ca2+ disruptions in young, adult, and aged Alzheimer's disease mice. J. Neurosci. 2006;26:5180–5189
  42. Taufiq AM, Fujii S, Yamazaki Y, Sasaki H, Kaneko K, Li J, et al. Involvement of IP3 receptors in LTP and LTD induction in guinea pig hippocampal CA1 neurons. Learn. Mem. 2005;12:594–600
  43. Tonkikh A, Janus C, El-Beheiry H, Pennefather PS, Samoilova M, McDonald P. Calcium chelation improves spatial learning and synaptic plasticity in aged rats. Exp. Neurol. 2006;197:291–300
  44. Tu H, Nelson O, Bezprozvanny A, Wang Z, Lee SF, Hao YH, et al. Presenilins form ER Ca2+ leak channels, a function disrupted by familial Alzheimer's disease-linked mutations. Cell. 2006;126:981–993
  45. Walsh DM, Klyubin I, Fadeeva JV, Cullen WK, Anwyl R, Wolfe MS, et al. Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature. 2001;416:535–539
  46. Wang Y, Wu J, Rowan MJ, Anwyl R. Role of protein kinase C in the induction of homosynaptic long-term depression by brief low frequency stimulation in the dentate gyrus of the rat hippocampus in vitro. J. Physiol. (Lond.). 1998;513:467–475
  47. Wang KT, Dineley JD, Sweatt JD, Zheng H. Presenilin 1 familial Alzheimer's disease mutation leads to defective associative learning and impaired adult neurogenesis. Neuroscience. 2004;126:305–312
  48. Wang Y, Chan SL, Miele L, Yao PJ, Mackes J, Ingram DK, et al. Involvement of Notch signaling in hippocampal synaptic plasticity. Proc. Natl. Acad. Sci. U.S.A. 2004;101:9458–9462
  49. Yang Y, Cook DG. Presenilin-1 deficiency impairs glutamate-evoked intracellular calcium responses in neurons. Neuroscience. 2004;124:501–505
  50. Yu QS, Pei XF, Holloway HW, Greig NH, Brossi A. Total syntheses and anticholinesterase activities of (3aS)-N(8)-norphysostigmine, (3aS)-N(8)-norphenserine, their antipodal isomers, and other N(8)-substituted analogues. J. Med. Chem. 1997;40:2895–2901
  51. Zekanowski C, Golan MP, Krzysko KA, Lipczynska-Lojkowska W, Filipek S, Kowalska A. Two novel presenilin 1 gene mutations connected with frontotemporal dementia-like clinical phenotype: genetic and bioinformatic assessment. Exp. Neurol. 2006;200:82–88

PII: S0197-4580(07)00412-5

doi: 10.1016/j.neurobiolaging.2007.10.009

Neurobiology of Aging
Volume 30, Issue 7 , Pages 1061-1068 , July 2009

Article Tools

* Image Usage & Resolution